Roth Capital Upgrades Celldex Therapeutics (CLDX) to Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. GNK
8. WDAY
9. ADYEN:NA
10. DVLT

January 17, 2012 7:56 AM EST
Get Alerts CLDX Hot Sheet
Price: $41.95 -1.55%

Rating Summary:
    18 Buy, 3 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Roth Capital upgraded Celldex Therapeutics (NASDAQ: CLDX) from Neutral to Buy, price target raised from $3 to $6.

For an analyst ratings summary and ratings history on Celldex Therapeutics click here. For more ratings news on Celldex Therapeutics click here.

Shares of Celldex Therapeutics closed at $3.15 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Upgrades

Related Entities

Roth Capital